INTRODUCTION
The SARS-CoV-2 (COVID-19) pandemic impacted around 472 million
people and killed around 6.09 million patients (1). Although the virus
is largely responsible for respiratory symptoms, a growing number of
dermatological signs and symptoms of this illness have been identified.
Several reports worldwide have identified a range of potential skin
manifestations of SARS-CoV-2 (COVID-19) (2-8). However, the
frequency of dermatological presentation (between 0.2% to 29%) and
also the timing of skin manifestations are difficult to ascertain
(9-11).
Here we have a case report of a young woman who initially presented with
a generalized pruritic urticarial rash ranging from one to seven
centimeters in diameter on the 6th of January 2022.